Business Context and Reporting Period
This Form 8-K Current Report was filed by Natera, Inc. on October 17, 2019, covering events occurring on October 15 and October 16, 2019. The Company, an emerging growth company incorporated in Delaware, announced and priced a public offering of its common stock.
Key Financial Metrics and Transaction Details
- Offering Size: 5,714,286 shares of common stock.
- Offering Price: $35.00 per share.
- Over-Allotment Option: Underwriters granted an option to purchase up to 857,142 additional shares, expiring November 15, 2019.
- Expected Net Proceeds: Approximately $188 million from the base offering; approximately $216 million if the over-allotment option is exercised in full (after deducting underwriting discounts, commissions, and estimated transaction expenses).
- Underwriters: J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC (as representatives).
- Closing Date: Expected on October 21, 2019, subject to closing conditions.
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period, as this document focuses solely on the capital raise transaction.
Material Changes
The primary material change is the entry into a Material Definitive Agreement (Underwriting Agreement) to raise capital. This represents a significant increase in the Company's equity capital and cash liquidity upon closing, though specific pre-offering balance sheet figures are not disclosed in this text.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on operational outlook, or specific risk factors beyond the standard closing conditions for the offering. The transaction is contingent upon the satisfaction of specified closing conditions.
Investor Verification Checklist
- Verify the final closing date of the offering (expected October 21, 2019).
- Confirm whether the underwriters exercised the 857,142 share over-allotment option.
- Review the final prospectus (File No. 333-234220) for detailed use of proceeds and updated risk factors.
- Check subsequent filings for the actual net proceeds received after final transaction expense adjustments.